Programs
Program 1 [2020]
INNOVATION HEALTH CENTER ISSUES CASE-SPECIFIC MEDICAL NECESSITY EVALUATIONS IN REGARD TO THE SYNAGIS DRUG; SUBMITS RECOMMENDATIONS ABOUT WHETHER PRIOR AUTHORIZATIONS (PA) SHOULD BE APPROVED OR DENIED, AND IF APPROVED, RECOMMENDATIONS ON THE AMOUNT OF THE DRUG; PERFORMS EXPEDITED REVIEWS; AND ENSURES THAT THE WEB-BASED PA PROCESS REFLECTS CURRENT GUIDELINES PER THE MOST CURRENT VERSION OF THE AMERICAN ACADEMY OF PEDIATRICS RED BOOK. AS NO SERVICE COULD BE FOUND IN COMMERCIAL BUSINESS, IHC PROGRAM SERVICES NOW INCLUDE THE PROCUREMENT OF SPECIAL METABOLIC FORMULA FOR ALL MEDICAID PATIENTS IN NC. IHC TAKES THE DOCTOR'S ORDERS AND ENTERS ORDERS, SPECIFIC TO EACH PATIENT, WITH METABOLIC FORMULA MANUFACTURERS. THE ORDERS ARE DROP SHIPPED TO THE PATIENT'S HOME COUNTY HEALTH DEPARTMENT FOR PICK UP. IN 2019, IHC BEGAN COLLABORATION ON A PILOT PROGRAM RELATED TO ENHANCED CARE COORDINATION AND COMPLEX CARE MANAGEMENT OF CHILDREN WITH MEDICAL COMPLEXITY CARED FOR IN NORTH CAROLINA. IN 2020, IHC EXPERIENCED DELAYS IN ADMINISTERING IT'S PROGRAMS DUE TO THE COVID-19 PANDEMIC.GeographiesNot indicatedDatesJan 1, 2020 – Dec 31, 2020Source990No causes providedNo populations provided–$1.2MInnovation Health Center Program
INNOVATION HEALTH CENTER (IHC) PROGRAM SERVICES INCLUDE THE PROCUREMENT OF SPECIAL METABOLIC FORMULA FOR MEDICAID PATIENTS IN NC. IHC TAKES THE DOCTOR'S ORDERS AND ENTERS ORDERS, SPECIFIC TO EACH PATIENT, WITH METABOLIC FORMULA MANUFACTURERS. THE ORDERS ARE DROP SHIPPED TO THE PATIENT'S HOME COUNTY HEALTH DEPARTMENT FOR PICK UP. IN 2019, IHC BEGAN COLLABORATION ON A PILOT PROGRAM RELATED TO ENHANCED CARE COORDINATION AND COMPLEX CARE MANAGEMENT OF CHILDREN WITH MEDICAL COMPLEXITY CARED FOR IN NORTH CAROLINA. IHC COLLABORATION RESUMED IN 2023 AFTER EXPERIENCING DELAYS IN ADMINISTERING SOME OF ITS PROGRAMS IN 2022, DUE TO DELAYS ENCOUNTERED BY THE FUNDED ENTITIES.GeographiesNot indicatedDatesJan 1, 2023 – Dec 31, 2023Source990No causes providedNo populations provided–$1.1M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)